Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis by an Endoscopic Pancreatic Spontaneous Dislodgement Stent

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 11, 2007, Pages 1339-1346

  Sofuni, Atsushi ^a   Maguchi, Hiroyuki ^b   Itoi, Takao ^a   Katanuma, Akio ^b   Hisai, Hiroyuki ^c   Niido, Teitetsu ^d   Toyota, Masayuki ^e   Fujii, Tsuneshi ^f   Harada, Youji ^d   Takada, Tadanori ^e  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b TEINE KEIJINKAI HOSPITAL   (Japan)

^c Japan Red Cross Date General Hospital   (Japan)

^d Toda Chuo General Hospital   (Japan)

^e TEIKYO UNIVERSITY HOSPITAL   (Japan)

^f ASAHIKAWA CITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREATIC STENT; PANCREATITIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STENT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMYLASES; BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC DISEASES; PANCREATIC DUCTS; PANCREATITIS; PROSTHESIS DESIGN; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 35549004394     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.07.008     Document Type: Article

References (33)

1. Freeman M.L., Nalini M., and Guda M. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59 (2004) 845-864
2. Freeman M.L., DiSario J.A., Nelson D.B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54 (2001) 425-434
3. Cheng C.L., Sherman S., Watkins J.L., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 101 (2006) 139-147
4. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 335 (1996) 909-918
5. Masci E., Toti G., Mariani A., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96 (2001) 417-423
6. Mehta S.N., Pavone E., Barkun J.S., et al. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 30 (1998) 457-463
7. Sherman S., Ruffolo T.A., Hawes R.H., et al. A prospective series with emphasis on the increased risk associates with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 101 (1991) 778-782
8. Vandervoort J., Soetikno R.M., Tham T.C., et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 56 (2002) 652-656
9. Elton E., Howell D.A., Parsons W.G., et al. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 47 (1998) 240-249
10. Fazel A., Quadri A., Catalano M.F., et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis?. A prospective randomized study. Gastrointest Endosc 57 (2003) 291-294
11. Tarnasky P.R., Palesch Y.Y., Cunningham J.T., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115 (1998) 1518-1524
12. Smithline A., Silverman W., Rogers D., et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 39 (1993) 652-657
13. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis?. A meta-analysis of controlled trials. Gastrointest Endosc 60 (2004) 544-550
14. Catalano M.F., Linder J.D., Chak A., et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 59 (2004) 225-232
15. Tsuchiya T., Itoi T., Sofuni A., et al. A temporary inner unflanged 5Fr pancreatic duct stent to prevent post-ERCP pancreatitis. A preliminary and single center randomized controlled trial study. Hep Bil Pancreatsurg (2006) (in press)
16. Sherman S., Lehman G., Freeman M., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 92 Suppl 9 (1997) 1639
17. Freeman M.L. Role of pancreatic stents in prevention of post-ERCP pancreatitis. J Pancreas 5 (2004) 322-327
18. Fogel E.L., Eversman D., Jamidar P., et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 34 (2002) 280-285
19. Aizawa T., and Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 54 (2001) 209123
20. Freeman M.L., Overby C., and Qi D. Pancreatic stent insertion: consequence of failure and results of a modified technique to maximize success. Gastrointest Endosc 59 (2004) 8-14
21. Vandervoort J., Soetikno R.M., Montes H., et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 49 (1999) 322-327
22. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37 (1991) 383-393
23. Tarnasky P., Cunningham J., Cotton P., et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 29 (1997) 252-257
24. Sherman S., Troiano F.P., Hawes R.H., et al. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc 36 (1990) 462-466
25. Rashdan A., Fogel E.L., Mchenry Jr. L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2 (2004) 322-329
26. Johnson G.K., Geenen J.E., Johanson J.F., et al. Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Gastrointest Endosc 46 (1997) 217-222
27. Andriulli A., Clemente R., Solmi L., et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56 (2002) 488-495
28. Tsujino T., Komatsu Y., Isayama H., et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol 3 (2005) 377-382
29. Cavallini G., Tittobello A., Frulloni L., et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 335 (1996) 919-923
30. Akashi R., Tanaka T., Kiyozumi T., et al. Severe abdominal pain in early stage of pancreatitis is helpful in the early recognition of aggravation of pancreatitis (in Japanese with English abstract). Nippon Suizou Gakkaishi 25 (2002) 205-211
31. Sherman S., Hawes R.H., Savides T.J., et al. Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP. Gastrointest Endosc 44 (1996) 276-282
32. Smith M.T., Sherman S., Ikenberry S.O., et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 44 (1996) 268-275
33. Raju G.S., Gomez G., Xiao S.Y., et al. Effect of a novel pancreatic stent design on short-term pancreatic injury in a canine model. Endoscopy 38 (2006) 260-265